The Untold Power of Low-Dose CT Scans for Lung Cancer
Cancer Conversations October 28, 2026x
3
00:24:1716.72 MB

The Untold Power of Low-Dose CT Scans for Lung Cancer



Welcome to another episode of Cancer Conversations! Today, Dr. Meadows tackles an urgent health topic: lung cancer, the number one cancer killer in the United States. Despite its prevalence, there’s a quick, simple, and effective screening, the low-dose CT scan that can catch lung cancer early and save lives, yet most eligible people have never even been offered this test. Dr. Meadows shares insights from a recent talk given to new doctors, reflects on why awareness of lung cancer screening lags behind other routine tests like mammograms and colonoscopies, and discusses what both patients and doctors can do to change this. If you or someone you know has a history of smoking, you won’t want to miss these potentially life-saving recommendations.

00:00 Starting a residency program

06:19 Developing lung cancer screening tools

07:24 Early detection of lung cancer

10:44 Importance of lung cancer screening

13:33 Raising awareness for lung cancer screening

19:04 Discussion on smoking history and screenings

21:54 Emphasizing the importance of screenings

25:33 Public health screening guidelines

26:47 Early detection for lung cancer


Early Detection Saves Lives: Insights on Lung Cancer Screening from Cancer Conversations

Lung cancer remains the number one cancer killer in the United States. Despite increased awareness and a decline in smoking rates over recent decades, the lethality of lung cancer means it continues to claim more lives than any other cancer. On this episode of Cancer Conversations, host layla and guest Dr. Meadows, a lung cancer specialist, discuss the powerful role early screening can play and why so few eligible people are taking advantage of it.

The Power of a Low-Dose CT Scan

One of the episode’s central messages is the transformative impact of a simple, non-invasive test: the low-dose CT scan. This quick procedure can detect lung cancer at an early, highly treatable stage, yet most people who qualify for it have never even been offered the test.

Dr. Meadows unpacks the history and efficacy of lung cancer screening at 00:06:19. Unlike chest X-rays, which were previously used for screening but lacked effectiveness, studies published in the New England Journal of Medicine in 2011 showed that annual low-dose CT scans could reduce lung cancer deaths by about 20%. Conducted on patients with a significant smoking history, the research found that the CT scan often catches cancers when they’re still small and localized long before symptoms appear.

Who Should Be Screened?

Drawing from the latest guidelines, Dr. Meadows clarifies the criteria: individuals aged 50–80 (recently lowered from 55 and expanded to 45 by some guidelines), with a 20-pack-year smoking history (one pack per day for 20 years, or two packs daily for 10 years), who are current smokers or have quit within the past 15 years, should get screened (00:26:06). He stresses that even those who stopped smoking years ago may still be at risk due to the long lag time between quitting and cancer emergence.

The Awareness Gap: Why Aren’t More People Screened?

Despite the robust evidence, only about 18% of those eligible for lung cancer screening receive it (00:13:27). By comparison, 76% of eligible women undergo mammography, and about 67% have colonoscopies. Dr. Meadows discusses how aggressive public awareness campaigns like Breast Cancer Awareness Month have normalized conversations and proactive screening around other cancers (00:12:22). Meanwhile, lung cancer suffers from both a lack of awareness and lingering stigma around smoking.

Medical professionals sometimes overlook ordering the test as well. In Dr. Meadows's experience training new residents, few had ever ordered a lung cancer screening for eligible patients (00:14:12). He emphasizes that educating both patients and physicians is essential.

The Crucial Role of Primary Care

Primary care providers, Dr. Meadows notes, are pivotal in closing this screening gap (00:15:43). They see many more patients than specialists do, and lung cancer screening should become as routine as mammograms or colonoscopies during annual visits. A busy primary care doctor might see 45 patients a day, multiplying their potential impact.

Overcoming Fear and Insurance Barriers

Many shy away from screening because they fear possible bad news. But as Dr. Meadows reminds us, catching lung cancer early dramatically increases the likelihood of cure. And while insurance complexities can deter some, most standard plans cover lung cancer screening for those who qualify (00:20:01).

The Takeaway: Know the Criteria, Save a Life

If there’s one thing Dr. Meadows wants listeners to remember, it’s the eligibility criteria (00:25:33): if you or a loved one is between 50 and 80 with a significant history of smoking, ask your doctor about a low-dose CT scan. This test has the power to detect lung cancer early, when it’s most curable.

Share and Advocate

Knowledge saves lives. If you think you or someone you care about could benefit from screening, share this episode and start the conversation. Spreading awareness “could really save a life.” Let’s work together to close the gap and make lung cancer screening a priority for all who need it.


SPEAKER_00

Lung cancer causes more cancer deaths than any other cancer. Yet a quick, simple, low-dose CT scan can actually find it at a stage where it's far more treatable.

SPEAKER_01

The folks who got the CT scans, we detected far more cancers. We cured far more of them. And when you looked at over the number of years, the survival curve, there was about a 20% reduction in the risk of dying from lung cancer. About 76% of the women who should get a mammogram get offered a mammogram. We go to lung cancer. And it's about 18%. Really low. And if we could bump up those numbers anywhere close to mammography or a colonoscopy screening, we save a lot more folks, bottom line.

SPEAKER_00

The number one cancer killer in the United States, and about a screening test that can actually catch it early, that most people who qualify have never been offered. Lung cancer causes more cancer deaths than any other cancer. Yet a quick, simple, low-dose CT scan can actually find it at a stage where it's far more treatable. Dr. Meadows recently did a speech and a talk and is gonna kind of walk us through a little bit that he touched on during that time and why the general population should know more about this scan and why so few people actually do, and also what we can do about it. But before we hop into things, it's great to see you, Dr. Meadows. How are you?

SPEAKER_01

I'm doing well, Layla. Good to be back. So I'm looking forward to sharing this with the audience here.

SPEAKER_00

Absolutely awesome. So do you want to talk about where you recently were? I know you did a talk.

SPEAKER_01

Yeah. So, you know, my home institution has started a residency program. And, you know, for folks in the in the audience, you know, residency is where doctors uh go to get trained. So there's academic institutions, community institutions uh that do this. You know, we're a community-focused uh institution, but as we uh transition to being more of an academic center, you know, one of the big things is that you start to train the next group of doctors. Uh, we started in internal medicine, which is kind of a core, you know, the adult, the the adult doctor that you see, the generalist primary care person for adults. So we started that training program. And the the folks that run it, you know, they ask us, hey, is there is there anything that, you know, some of you specialists could share with us that you think would be useful to our trainee, right? And so as I started to think about it, I mean, a natural thing that came to mind was, hey, I know as a as a lung cancer specialist that screening for lung cancer is underutilized. And that's very much in the wheelhouse of the primary care folks. So I recently gave a talk to our trainees and trying to get them up to speed and be aware when they see folks in their clinic that are eligible for this essentially life-changing but very underutilized test, they start to order it more.

SPEAKER_00

And it's interesting, and this is me coming from not a medical background, but it's a little surprising to hear that lung cancer is the leading cancer, being that I think lung cancer is often associated with smoking. And smoking, you know, years ago, decades ago, was so much more popular, socially acceptable, and relevant than it is now. So it's interesting to hear that that's still the case.

SPEAKER_01

One of the slides that I showed that got interesting reaction from the residencies, I say, listen, the world before 1970, in terms of our attitudes towards smoking. Now, I was born in 75, so I didn't like kind of grow up in this world, but I go, I went back and I looked at some of the advertising that used to be out there for cigarettes. I mean, you had celebrity, you had sports figures, you had doctors. There were actually ads with doctors in there pitching cigarettes as treatment for asthma and whatnot. So when you look at cigarette consumption, it really kept just steadily climbing uh throughout the early part of the 1900s up until 1970. And really, one of the most powerful things we ever did that at least it stopped the increase, and then we started to see a steady decline in smokers. They outlawed advertising and mainstream sources for cigarettes in the early in the early 70s, right? And then you started to see this nice gradual decline in the number of smokers. And then we've done other things too, where you know, we basically made it illegal to like, you know, smoke in restaurants and like hospitals and public spaces and all that. So the number of people smoking has steadily gone down, but owing to the lethality and how how how tough lung cancer is, it's still the number one killer. Even though the number of people who are smoking and therefore the number of cases is going down is still the number one killer.

SPEAKER_00

I remember even growing up, the Marlboro man and the camel. Exactly.

SPEAKER_01

Yeah.

SPEAKER_00

All those there were just images of cigarettes being cool and smoking being cool.

SPEAKER_01

And so, yeah, I had the Marlboro man on there, and I was explaining to them that, you know, one of the kind of teen rebellion idols was James Dean. He was a movie star in the 60s, and they they show him smoking and stuff like that. So, like before there was, you know, dyed hair and tattoos and ripped jeans and whatnot, you know, smoking cigarettes was, you know, teen rebellion kind of thing, too, and idolized. So yeah, kind of interesting. Very different world.

SPEAKER_00

It was idolized and rebellion, and also like the cool kids kind of doing it. Like that's what we saw even in the shows, even in I don't know, this is a random example that popped in my head, but there was an episode of Full House, and it was like the cool girl smoking in the bathroom as like the rebellious thing to do and and hiding it in all those like 90s shows. It was it was such a big thing. Then I remember as it changed, and I remember I think it was some kind of legality, as you mentioned, where those images weren't allowed to be shown anymore, and the warning labels were more obvious and evident. So I remember that that change. So it's still kind of mind-blowing that it's still the leading cause. Let's talk a little bit about the CT scan you mentioned. So tell us about the low-dose CT screening. What is it exactly and how well does it really work?

SPEAKER_01

Yeah, so you know, we we've had things like mammography, we've had the colonoscopy. So, you know, we've had effective screening tools for other common cancers. And so obviously, looking at how lethal lung cancer is, we've been looking for an effective screening tool. We had looked at chest x-rays in the past, and honestly, that data wasn't great. And so the idea came that, hey, every once in a while, we would accidentally catch a little small lung cancer. Oftentimes, when a patient was getting the imaging done for something else, routine surgical clearance uh for an operation, say for instance, or they're getting a CAT scan for something else, like a cardiac chest pain or whatever. And we and we would every once a while we catch these little small nodules that wound up being lung cancer. And we catch them way earlier than the typical presentation of lung cancer is when, you know, it's much bigger. It's causing symptoms, it's causing coughing, it's causing people to, they're coughing up blood, they're losing weight, they're having obstruction. You know, that's the that was the typical presentation of lung cancer. And we didn't cure very many of those folks. And so we saw, like, man, the the folks that we can really cure, we kind of catch them early with these CT scans. So why not see if doing a regular CT scan on a person who's deemed to be high risk, right? So we're not gonna do it on anybody. They have to have the appropriate smoking history and therefore be at risk. You have to remember about 90, 90% of folks that have lung cancer have a strong smoking history. There's a component that don't, but most of them do. So back in, I think it was the original data was published in 2011 in the New England Journal of Medicine. And generally speaking, you know, when you have a clinical trial that's published in the New England Journal of Medicine, which I still think, you know, as is still kind of the number one journal as far as prestige goes, it's it's a heavy-hitting study. And what they did was they took folks who had at least a 30-pack year smoking history. I mean, I think the original age criteria is it had to be 50 and above. Okay. So again, big time risk for lung cancer. It's not the general population. And they, and it was a big study, 50,000 folks. And when you have a really big study like that, it increases the statistical power and the certainty that if you see a difference between the groups, you know it's real due to your intervention. You have that many folks. So they randomized these folks to three consecutive annual CT scans of the chest versus three consecutive chest x-rays. Okay. And they followed these folks over many years. And the headline was is that the folks who got the CT scans, we detected far more cancers. We cured far more of them. And when you looked at over the number of years, the survival curve, there was about a 20% reduction in the risk of dying from lung cancer in the folks that got the low dose CT scan. This was a big, big finding. Okay. Like we finally have proof that something we can do on the screening front can meaningfully decrease the risk of dying from lung cancer. The issue was that we were shifting these folks from really stage four disease all the way up to stage one disease, where surgery and or high dose radiation way, way more effective. Okay. So that was the big, big deal. And that led to the relatively rapid rollout of the recommendation to start to screen these smoking uh patients. Okay. So that's the that was that's the big deal about the screening study.

SPEAKER_00

And then you touched on it that usual people who do have lung cancer for the most part have a significant smoking history. But what happens in the cases where let's say someone smoked, but maybe they quit 20 years ago, or someone who hasn't smoked?

SPEAKER_01

Yeah, and I should, and I and I should mention that when you look at the big epidemiological data on like, you know, people that smoke, and then like when does that lung cancer hit? It can oftentimes be a 15, 20 year lag, right? So I should point out in that original trial, there were folks that were current smokers, or if you quit within the past 15 years, but you still had that 30 pack year smoking history, you were allowed to be in the test because they they we were allowed to be in the study because they still recognized you were at high risk. So, yeah, former smokers, but if you're a former heavy smoker, you should get screened too. Absolutely.

SPEAKER_00

This kind of goes back to my point of what I like my thought process earlier about thinking, you know, again, someone who's not in the medical field, I hear cancer. I always think of like maybe breast cancer being the number one or more popular. But, you know, maybe it's because we hear about mammograms all the time or we hear about colonoscopies all the time. So why do you think or why does lung cancer screening lag so kind of far behind, if you will?

SPEAKER_01

Yeah. So to just put some numbers on it, right? When you look at the the main screening test that we order, so out of the women who are eligible to get a mammogram, okay, and mammography is kind of the gold standard, about 76% of the women who should get a mammogram get offered a mammogram. I mean, I wish it was 95 or 99% or whatever, but that's about the highest and best used screening test that we have. And of course, you know, that has come about through years of public awareness marketing. You know, we've got we've got breast cancer awareness month. We've got, you know, everybody busts out their pink, you know, even NFL teams wear pink, you know, during breast cancer awareness month. So, you know, it's well out there and everything, and women know about it. Look at the the next one, a colon cancer and a colonoscopy, right? It's about 67% of the people that should get a colonoscopy get one. Again, I wish it were higher, but it's well above half. Now, again, do I wish those numbers were more like 90%? Yes. Then one that kind of legitimately surprised me a little bit was PSA screening, which is just a simple blood test that you get. I thought that would be higher, but when you look at the data, only about 35% of men who are eligible for PSA screening actually get it. So that wouldn't, that wouldn't legitimately surprise me. So we're we're we're underutilizing that too. Okay, so that's another one. But then you go you go to lung cancer screening, and it's about 18%, right? So really, really low, really low. That would be pretty abysmal. And again, when you look at the fact that lung cancer is the number one killer, you would hope those numbers would be way, way higher. Okay. So part of the big issue that we know, one issue, is that honestly, I mean, the data's been out there, but in terms of like really like a public awareness push, marketing, awareness amongst physicians and everything. And we're, you know, I just polled the room. Now, again, these are these are doctors in training, right? But I do just kind of poll the room. They're seeing folks in clinic, you know, this, they're learning something. And some of them, some of their professors asked them, like, how many of you guys have ordered a lung cancer screening uh on some of the folks you've seen in clinic? And out of the maybe 30 folks in the room, maybe like four or five, you know, put up their hand, you know. So part of my job is is to at least educate my colleague. I would love for us to get some kind of more mainstream, you know, push on this. But uh, but yeah, certainly the education piece amongst the doctors needs to be fixed.

SPEAKER_00

And then touching on doctors, what what about primary care doctors? So, what role do primary care doctors play and what should patients expect?

SPEAKER_01

Well, as a general rule, right, the the whole screening thing, it is very much in their purview, right? So, you know, at a minimum, when you when you go to like a your primary for kind of like your annual thing, right? You know, it should consist of, of course, a you know, a good history of what's been going on with you the past year. There's kind of like these routine labs that they're always gonna get, you know. And again, a PSA, for instance, that should be kind of part of it, your routine screen, right? And whatnot. They should ask you, hey, have you had a colonoscopy in the last 10 years? You know, and if you haven't, you know, let's let's get you one. And of course, if you're a woman, a yearly mammogram. So these things are kind of ingrained in there. But then, you know, they've been trained to do some smoking cessation stuff. Like if a person is a smoker, that's kind of part of the routine thing. But for whatever reason, we're ordering that that low-dose CAT scan, not so much. And we got to get them to do it because they see the bulk of the patient. Now, interestingly, I see some patients in my follow-up clinic who have this smoking history. So smoking causes a lot of cancers, right? Not only lung cancer, but things like head and neck cancer, tons, tongue cancer, esophagus cancer, that kind of thing. So I will see somebody and treat somebody for that cancer, cure them, you know, and they're doing well. And I'm seeing them in follow-up for that, but they've and they've got that smoking history. And I'll order a low dose cap scanner. I found lung cancers on some of my patients. But again, the number of folks that I'm gonna see versus like what a primary care is gonna see, he has much more ability to impact that with the sheer volume of smokers you don't see compared to me in his clinic, you know. I might see 15 total patients a day, a busy primary care doctor might see 45 folks a day. You know what I mean? So, you know, you kind of do the math, right? And then to kind of talk about how effective the lung cancer screening is versus those other tests, right? When you look at the number of folks you need to screen to save one life with a mammogram, or I think the other one was PSA screening for prostate cancer. The number's about 1,400 folks you have to screen in order to save one life, right? How many folks do you need to screen for lung cancer to save one life? It's like 320. That speaks to number one, the effectiveness of the screening test and also the lethalness of lung cancer, right? So again, if we could bump up those numbers anywhere close to mammography or a colonoscopy screening, we we save a lot more folks, the bottom line.

SPEAKER_00

It is such a drastic number. I never really thought about that. How many more patients of a primary care provider would see that would be able to kind of have that insight and that connection with the patient?

SPEAKER_01

Correct. Yeah, it's it's a big deal. And, you know, one thing that the that I that I do agree with that the powers that be have done is that they, in an effort to try to capture more people in the screening cohort, they actually lowered down the number of pack years that was required to be part of the study. In the original study, you had to have a 30-pack year smoking history. Well, when they saw that the the amount of people getting screened was already low, they're like, well, let's broaden this out a little bit so at least we can more people eligible. So they actually lowered that down to just a 20-pack year smoking history, right? And I believe they actually lowered the age cohort down. I think in the in the original study it was 55 and above, and they lowered it down to 50. You know, again, that's good, you know, broaden the criteria folks that need a screening, but still it it's more of a an awareness thing, though, with the with a number that low at 18%.

SPEAKER_00

Yeah, absolutely. And what about someone who's listening to today's show and they think that they might qualify? So what should they do next? What would the first steps be?

SPEAKER_01

Well, yeah. So obviously, you know, our show here is aimed at the general public. So if you're sitting here, and of course, if you yourself fit this criteria where you've got that pack year smoking, and let's talk about pack years, just to define it, right? So a pack year is like, hey, if I smoked one pack a day for 20 years or two packs a day for 10 years, say for instance, right? And believe it or not, not too much anymore. But I I have had a few folks that admitted to smoking three packs a day. I guess that only that only takes you like seven years or whatever to qualify for that 20 pack year smoking history. So, you know, if so if if you fit that criteria, or if a loved one that you know of fits that criteria, I think the number one thing to do would be like, hey, let me chat with my primary care doc and like, you know, can I get this order? Because it's an accepted screening, a tool and everything. I mean, the vast majority of any insurance is going to cover it. I know that one other thing that we were doing at our institution in order to foster nobody not getting the test because of insurance, we were like defraying the cost of it and that kind of thing. And we didn't want cost to be a big burden. But I know most people's insurance cover a standard screening test. And and also, and they call it a low-dose CAT CT scan. And they're using about one-seventh the radiation that's used in a typical regular CAT scan. In an effort to, you know, not expose people to any unnecessary radiation, but get a good enough image for what we're looking for, which are these little small uh spots in the lung. So that's uh that's another thing. So coverage is not so much an issue, but I think it's more so an awareness kind of thing.

SPEAKER_00

It is good to know too, because insurance obviously is complex and there's so many complexities to it. And a lot of people, patients especially, are overwhelmed and confused by insurance that even if they know about it, they might not think that it will be covered. So having the awareness to know about it is so important because then you can know that this exists, and especially if you qualify and then figure out the insurance piece. And like you said, it should be covered, like the standard one.

SPEAKER_01

And you're right about insurance. You know, everybody's things is is different. But as a fairly accurate general statement, you know, standard screening tests are covered by most people's insurance, but not at all. Yeah. Yeah.

SPEAKER_00

Absolutely. And then I know you covered so much at the recent talk that you were at. So what else did you kind of touch on or review during that time that we didn't discuss today and during this episode? Is there anything that you wanted to bring up or shed some light on?

SPEAKER_01

I wanted to encourage my primary care colleagues. I was like, listen, in this particular instance, right, a well-informed primary care physician that is screening everybody, right? They can over the course of their career, you know, really impact a number of cancer patients, honestly, just as impactful as me doing the actual treatment itself, right? This screening thing, screenings, screening tests and public policy, they trump advances in treatment. You know what I mean? And that that was the thing I wanted to kind of emphasize to them. You know, we we market how fancy we've gotten with radiation, and we have, and it's much better, right? The the the the types of different drugs and and different chemotherapy and immunotherapy and biologic agents and all that. That's all kind of, you know, those are the kind of advances that are sexy to kind of market and talk about, and they're real, right? But the public policy to stop advertising about cigarettes and a great screening test, when you look at like how many people that can actually save, it trumps all the fancy treatment. So I just kind of wanted to make them know that like you guys can, you know, really impact things.

SPEAKER_00

Absolutely. No, that is such a good, a good point. And like you said, it could have such a huge effect on so many more people. So we covered a lot of good information so far on this episode, but I think it's important to for our listeners to wrap it up with one good thing. So if there's something that our listeners could take away from this show and this episode, what do you think it would be? Or what do you hope it would be?

SPEAKER_01

Well, you know, it again, it's aimed at the general public, if they could just, you know, memorize in their head, you know, just like how we have, like, hey, I'm a woman, I'm age 40 and up, you know, let's go get a yearly mammogram kind of deal, right? If I'm a if I'm a an adult age, it used to be 50, and they lowered it down to 45. I need to start getting my my colonoscopy done and that kind of. So if I could get folks to just memorize the basic eligibility criteria, right? And I guess I would say, hey, the 20-pack year smoker, right? If you or somebody you know fits that criteria, okay, and they could be a current smoker, or if they've quit any time in the past 15 years, right? They've got that 20-pack year smoking history, they should be getting a low dose CT scan of their chest starting at age 50. A lot of numbers, but yeah, if I could get folks to kind of keep that in mind, that would be huge.

SPEAKER_00

Absolutely. And this is such good information for so many people, especially in that age demographic that smoked, like you said, pack a pack or several packs, up to three packs a day. Super important for them to know that this is something that they should be checking regularly to stay on top of their health and prevent anything and be in the know about everything that's going on. And I think that this information has been so helpful for people to know that this does exist. And for all of our listeners, thank you for joining us for another episode of Cancer Conversations. And the takeaway, I think, is simple. Lung cancer is our number one cancer killer, and we have a powerful test. Then catch it early. It does exist, as Dr. Meadows really broke it down for us today. And especially if you are the ages between 50 and 80 and have had significant smoking history, past or present, ask your doctor about a low dose ET scan. And if you know someone who might qualify and this episode can help, make sure that you do share this episode and pass this along to everyone because this is great information for everyone to know. It could really save a life. And thank you, Dr. Meadows, for this great information. It's a pleasure speaking with you as always. And to our listeners, make sure that you follow, subscribe, and share the show so you don't miss our next episode. And we'll talk soon.

unknown

All right.

SPEAKER_01

Thank you.